Virtu Financial LLC Vista Gen Therapeutics, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.14 - $4.8 $32,303 - $1.11 Million	230,742 New	230,742 $35,000
Q2 2022 Aug 09, 2022	SELL	$0.88 - $1.73 $10,716 - $21,067	-12,178 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.14 - $2.09 $9,499 - $17,415	-8,333 Reduced 40.63%	12,178 $15,000
Q4 2021 Feb 17, 2022	BUY	$1.67 - $2.76 $34,253 - $56,610	20,511 New	20,511 $40,000
Q2 2021 Sep 17, 2021	SELL	$1.96 - $3.15 $121,763 - $195,690	-62,124 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$1.89 - $2.96 $117,414 - $183,887	62,124 New	62,124 $132,000
Q2 2020 Aug 07, 2020	SELL	$0.37 - $0.61 $5,865 - $9,670	-15,854 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$0.3 - $1.41 $13,594 - $63,895	-45,316 Reduced 74.08%	15,854 $11,000
Q3 2019 Nov 20, 2019	BUY	$0.46 - $1.29 $28,138 - $78,909	61,170 New	61,170 $65,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.